Blog
NeuroSense strives to make science, research and clinical development accessible to patients, family members, caregivers, and the scientific community. Therefore, we have created a blog that will touch upon different aspects of drug development, neurodegenerative diseases, research and development, science, biotech and business. Check this page regularly for informative and timely updates.
NeuroSense featuring the Lead CRA
“It is especially important to create strong relationships with all of the people involved in the study to make sure that there is effective collaboration.”
NeuroSense featuring the VP Regulatory Affairs
“The feeling of successfully navigating the regulatory landscape and achieving drug approval is indescribable”
NeuroSense featuring the CFO
“R&D companies like NeuroSense are doing the greatest thing any company can do. Financially, they are taking an enormous risk with a drive to change
NeuroSense featuring the VP R&D
“If you haven’t experienced failure, you may not be aiming high enough.”
NeuroSense featuring the Regulatory Affairs Director
“Plan ahead and tackle tasks early. Do things right the first time”
NeuroSense featuring the Scientific Project Manager
“Seeing how an individual living with ALS could benefit so much from the technology I helped create, I was inspired to dedicate myself to finding
NeuroSense featuring the CEO
“The most rewarding aspect of leading NeuroSense is hearing how we have improved people’s lives”
The Luckiest Man On Earth
“Today I consider myself the luckiest man on the face of the earth.” — Lou Gehrig Yankee stadium retirement speech, July 4, 1939.
Breaking The Paradigm – Novel Approaches To ALS Therapy
How are new medications created? How does an idea for a treatment lead to the development of a product? How do you choose the right
Join Our Newsletter
